Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate Temporomandibular Joint Osteoarthritis by Suppressing Osteoclast Activity Via let-7a-5p/Integrin β3 Axis
ACS Nano · 2025
DOI: 10.1021/acsnano.5c11211 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Zhihua Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, Shenzhen University Medical School, Shenzhen 518015, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Osteoarthritis, MicroRNAs, Mesenchymal Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen University, Shenzhen Medical Academy of Research and Translation.
Abstract (Originalsprache)
Temporomandibular joint osteoarthritis (TMJOA) is a common degenerative oral disease and remains one of the most challenging joint disorders to treat clinically. It is characterized by excessive subchondral bone loss at an early stage and cartilage damage at a later stage. In recent years, mesenchymal stem cell (MSC) derived extracellular vesicles (MSC-EVs) have attracted widespread attention for their potential role in modulating OA pathology. However, the application of MSC-EVs in TMJOA remains underexplored, and the mechanisms underlying their therapeutic effects are not fully understood. In this study, we evaluate the therapeutic effects of human umbilical cord mesenchymal stem cell-derived extracellular vesicles (hUCMSC-EVs) on TMJOA, with a focus on subchondral bone, and investigate their underlying molecular mechanisms through miRNA sequencing. The results demonstrated that hUCMSC-EVs treatment significantly reduced osteoclast (OC) activity by transferring let-7a-5p, which further suppressed the expression of integrin β3 (ITGβ3) of osteoclasts. In a rat TMJOA model, intra-articular injection of hUCMSC-EVs demonstrated protective effects on both subchondral bone and cartilage, primarily through the suppression of osteoclast activity. Consequently, these results highlight the potential of hUCMSC-EV-based therapies as promising and effective approaches for the treatment of TMJOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dentistry, Shenzhen University Medical School, Shenzhen 518015, China.
- School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518015, China.
- Institute of Oral science, Shenzhen University, Shenzhen 518055, China.
- Department of Stomatology, Shenzhen University General Hospital, Shenzhen University, Shenzhen 518055, China.
ORCID-Profile: Yang Zhang
Förderung
- Shenzhen University
- Shenzhen Medical Academy of Research and Translation
Zitieren
APA
Yang, Z., Zhang, S., Faqeer, A., Anjum, S., Deng, Y., Cao, J., Yu, T., & Zhang, Y. (2025). Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate Temporomandibular Joint Osteoarthritis by Suppressing Osteoclast Activity Via let-7a-5p/Integrin β3 Axis. ACS Nano. https://doi.org/10.1021/acsnano.5c11211
Vancouver
Yang Z, Zhang S, Faqeer A, Anjum S, Deng Y, Cao J, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate Temporomandibular Joint Osteoarthritis by Suppressing Osteoclast Activity Via let-7a-5p/Integrin β3 Axis. ACS Nano. 2025. doi:10.1021/acsnano.5c11211
BibTeX
@article{Yang2025,
author = {Yang, Zhihua and Zhang, Shiying and Faqeer, Abdullah and Anjum, Shabnam and Deng, Yongqiang and Cao, Jun and Yu, Taozhao and Zhang, Yang},
title = {Mesenchymal Stem Cell-Derived Extracellular Vesicles Ameliorate Temporomandibular Joint Osteoarthritis by Suppressing Osteoclast Activity Via let-7a-5p/Integrin β3 Axis},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c11211}
}
EUVIMED